I would like to thank Wilbert Escorcia, who recently also joined this blogging site, for having shown me the PBS site as another great source of information on the internet.
He shared with me the profile of one of the people who are and will likely make a big difference in the sustainable biotechnology field: Jay Kiesling, founder of Amyris Biotechnologies, which was originally known for a bio-based method to efficiently and affordably produce artemisinin, an anti-malarial drug. Amyris Biotechnologies was a company I previously wrote about in my coverage of bio-based companies in California.
On a Personal Note:
Before, we dive into the video, I would just like to throw in a personal note. In light of the latest discussion about federal funding for public media on capitol hill, I think it is important to emphasize that the unique service public broadcast and radio provides - namely to inform and educate affordably, and broadly - is almost completely absent anywhere else in the entire American media landscape. A thriving democracy depends on a well-educated and informed general public, and so the services that public media provide, in my opinion, represent a rare beacon of light in support of our democracy in the ocean of sensationalist eye witness news reporting and opinionated quasi news shows on the major cable networks (Disclaimer: I don't think highly of the current quality of news coverage provided by most of the current US cable news outlets.). Right now public media (both radio and broadcast) are having their spring membership drive. No matter where you stand on the debate on whether to help fund public media federally, contributions from individuals like yourself are even more important this time around. And so, with the risk of sounding just like a member drive spokes person, I hope that you will consider doing the right thing.Thank you!
He shared with me the profile of one of the people who are and will likely make a big difference in the sustainable biotechnology field: Jay Kiesling, founder of Amyris Biotechnologies, which was originally known for a bio-based method to efficiently and affordably produce artemisinin, an anti-malarial drug. Amyris Biotechnologies was a company I previously wrote about in my coverage of bio-based companies in California.
On a Personal Note:
Before, we dive into the video, I would just like to throw in a personal note. In light of the latest discussion about federal funding for public media on capitol hill, I think it is important to emphasize that the unique service public broadcast and radio provides - namely to inform and educate affordably, and broadly - is almost completely absent anywhere else in the entire American media landscape. A thriving democracy depends on a well-educated and informed general public, and so the services that public media provide, in my opinion, represent a rare beacon of light in support of our democracy in the ocean of sensationalist eye witness news reporting and opinionated quasi news shows on the major cable networks (Disclaimer: I don't think highly of the current quality of news coverage provided by most of the current US cable news outlets.). Right now public media (both radio and broadcast) are having their spring membership drive. No matter where you stand on the debate on whether to help fund public media federally, contributions from individuals like yourself are even more important this time around. And so, with the risk of sounding just like a member drive spokes person, I hope that you will consider doing the right thing.Thank you!
Watch the full episode. See more NOVA scienceNOW.